GLOBAL ROSUVASTATIN CALCIUM MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024
- Id : RNR-264813
- Category : Pharma Healthcare
- Publish Date : Apr-19
- Publisher : Research-N-Reports
- Pages : 123
- Format : PDF
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation). Scope of the Report: With the raw material advantage, EU is the dominate producer and exporter in rosuvastatin calcium industry. The production market share of EU has reached about 35.25% in 2015. In additional, EU is also the largest consumer of rosuvastatin calcium, about 34.47% of the global production was consumed in EU in 2015. China is the second producer with the market share of 28.82% in 2015. Top Three manufacturers in rosuvastatin calcium are AstraZeneca, MSN Laboratories, Changzhou Pharmaceutical Factory, according for 55.09% of the total amount in 2015. The worldwide market for Rosuvastatin Calcium is expected to grow at a CAGR of roughly 4.1% over the next five years, will reach 550 million US$ in 2024, from 430 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Rosuvastatin Calcium in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers - AstraZeneca - Teva Pharmaceutical Industries - MSN Laboratories - Cadila Pharmaceuticals - LGM Pharma - Bal Pharma - Changzhou Pharmaceutical Factory - Jingxin Pharm - Zhejiang Hisun Pharmaceutical - HEC Pharm - Lunan Pharmaceutical - Nanjing Frochem Tech - Lianyungang Runzhong Pharmaceutical - Shandong Bechem Chemicals - CTX Life Sciences - Others Market Segment by Regions, regional analysis covers - North America (United States, Canada and Mexico) - Europe (Germany, France, UK, Russia and Italy) - Asia-Pacific (China, Japan, Korea, India and Southeast Asia) - South America (Brazil, Argentina, Colombia etc.) - Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers - Purity 98.0% - Purity 99.0% - Other Market Segment by Applications, can be divided into - Tablet (including dispersible tablet and general tablet) - Capsule - Others The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Rosuvastatin Calcium product scope, market overview, market opportunities, market driving force and market risks. Chapter 2, to profile the top manufacturers of Rosuvastatin Calcium, with price, sales, revenue and global market share of Rosuvastatin Calcium in 2017 and 2018. Chapter 3, the Rosuvastatin Calcium competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Rosuvastatin Calcium breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019. Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019. Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019. Chapter 12, Rosuvastatin Calcium market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024. Chapter 13, 14 and 15, to describe Rosuvastatin Calcium sales channel, distributors, customers, research findings and conclusion, appendix and data source.